Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Garland

Showing results (701-710 of 803) with videos related to

Pageof 81
Sort By:
AIDS (London, England)|March 22, 2017
The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual menFengyi Jin, Jennifer M Roberts, Andrew E Grulich, et al.
Nature Communications|July 19, 2024
Emittance preservation in a plasma-wakefield acceleratorC A Lindstrøm, J Beinortaitė, J Björklund Svensson, et al.
The Journal of Infectious Diseases|January 2, 2023
Performance of Human Papillomavirus Attribution Algorithms to Predict Causative Genotypes in Anal High-Grade LesionsSamuel Phillips, Alyssa M Cornall, Monica Molano, et al.
Trauma Surgery & Acute Care Open|February 26, 2021
Decreased adult trauma admission volumes and changing injury patterns during the COVID-19 pandemic at 85 trauma centers in a multistate healthcare systemGina M Berg, Ransom J Wyse, Jennifer L Morse, et al.
The Journal of Infectious Diseases|August 30, 2024
Human Papillomavirus Prevalence Among Australian Men Aged 18-35 Years in 2015-2018 According to Vaccination Status and Sexual OrientationPrisha Balgovind, Eithandee Aung, Hannah Shilling, et al.
Vaccine|November 27, 2019
Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screeningHannah Shilling, Gerald Murray, Julia M L Brotherton, et al.
Gynecologic Oncology|April 16, 2019
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo populationAnna R Giuliano, Elmar A Joura, Suzanne M Garland, et al.
Open Forum Infectious Diseases|July 19, 2018
Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV VaccineZheng Quan Toh, Kathleen Wen Bei Cheow, Fiona M Russell, et al.
Journal of Trauma Nursing : the Official Journal of the Society of Trauma Nurses|July 8, 2022
What Makes a Trauma Patient "Pediatric"? Survey of Providers' Admission Decision Making for Pediatric Trauma PatientsSamir M Fakhry, Gina M Berg, Nina Y Wilson, et al.
The Journal of Infectious Diseases|November 6, 2016
Human Papillomavirus Prevalence in Unvaccinated Heterosexual Men After a National Female Vaccination ProgramDorothy A Machalek, Eric P F Chow, Suzanne M Garland, et al.
Pageof 81

Showing results (701-710 of 803) with videos related to

Sort By:
Pageof 81
AIDS (London, England)|March 22, 2017
The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual menFengyi Jin, Jennifer M Roberts, Andrew E Grulich, et al.
Nature Communications|July 19, 2024
Emittance preservation in a plasma-wakefield acceleratorC A Lindstrøm, J Beinortaitė, J Björklund Svensson, et al.
The Journal of Infectious Diseases|January 2, 2023
Performance of Human Papillomavirus Attribution Algorithms to Predict Causative Genotypes in Anal High-Grade LesionsSamuel Phillips, Alyssa M Cornall, Monica Molano, et al.
Trauma Surgery & Acute Care Open|February 26, 2021
Decreased adult trauma admission volumes and changing injury patterns during the COVID-19 pandemic at 85 trauma centers in a multistate healthcare systemGina M Berg, Ransom J Wyse, Jennifer L Morse, et al.
The Journal of Infectious Diseases|August 30, 2024
Human Papillomavirus Prevalence Among Australian Men Aged 18-35 Years in 2015-2018 According to Vaccination Status and Sexual OrientationPrisha Balgovind, Eithandee Aung, Hannah Shilling, et al.
Vaccine|November 27, 2019
Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screeningHannah Shilling, Gerald Murray, Julia M L Brotherton, et al.
Gynecologic Oncology|April 16, 2019
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo populationAnna R Giuliano, Elmar A Joura, Suzanne M Garland, et al.
Open Forum Infectious Diseases|July 19, 2018
Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV VaccineZheng Quan Toh, Kathleen Wen Bei Cheow, Fiona M Russell, et al.
Journal of Trauma Nursing : the Official Journal of the Society of Trauma Nurses|July 8, 2022
What Makes a Trauma Patient "Pediatric"? Survey of Providers' Admission Decision Making for Pediatric Trauma PatientsSamir M Fakhry, Gina M Berg, Nina Y Wilson, et al.
The Journal of Infectious Diseases|November 6, 2016
Human Papillomavirus Prevalence in Unvaccinated Heterosexual Men After a National Female Vaccination ProgramDorothy A Machalek, Eric P F Chow, Suzanne M Garland, et al.
Pageof 81